Application 202931
- Type
- ANDA
- Sponsor
- MYLAN
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | FROVATRIPTAN SUCCINATE | FROVATRIPTAN SUCCINATE | TABLET;ORAL | EQ 2.5MG BASE | No | No |
NDC Listings For This Application#
| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|---|---|---|---|---|
| 0378-3140 | Frovatriptan | frovatriptan | Mylan Pharmaceuticals Inc. | ANDA | Current |
| 0378-3140 | Frovatriptan | frovatriptan | Mylan Pharmaceuticals Inc. | ANDA | Current |
| 0378-3140 | Frovatriptan | frovatriptan | Mylan Pharmaceuticals Inc. | ANDA | Current |